Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
VNRX
$0.54
-14.78%
VNRX · Volitionrx Ltd
$0.54
-0.09 (-14.78%)
At close · Aug 14
View the 10-K filed Mar 31, 2026
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company concluded that these plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Customer concentration
— top 2 customers 38% of receivables
2 customers — 38% of receivables (December 31, 2025)
“At December 31, 2025 the two largest customer balances represented over 38% of the total outstanding accounts receivable balance.”
Market Cap
$7.34M
Shares
13.65M
All earnings calls
Earnings call · FY2019 Q4
Volitionrx Ltd Q4 FY2019 Earnings Call
Volitionrx Ltd Q4 FY2019 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Net income · derived Q4
-$3.56M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 20, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 20, 2020 · complete as-filed document